White Paper

Formulation Considerations For Over-Encapsulation Of Clinical Trial Materials In DBcaps® Capsules

Source: Capsugel® | Lonza Pharma & Biotech

This paper provides a technical review of formulation considerations relating to the use of gelatin DBcaps capsules for clinical trials, as well as a list of published references. Submitted by Capsugel

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: